z-logo
Premium
Pityriasis rosea infection in a COVID ‐19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS‐CoV ‐2 infection
Author(s) -
Paolino Giovanni,
Di Nicola Matteo Riccardo,
Cantisani Carmen,
Mercuri Santo Raffaele
Publication year - 2021
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.14972
Subject(s) - medicine , antihistamine , covid-19 , pityriasis rosea , telemedicine , dermatology , virology , anesthesia , health care , disease , outbreak , infectious disease (medical specialty) , economics , economic growth

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom